The Cabrini Cancer Center is staffed by a three-physician hematology and oncology team supported by three advanced practice providers, dedicated infusion nursing, and a one-to-one medical assistant model. Providers are split across two locations, Cabrini Cancer Center South on the hospital campus and Cabrini Cancer Center North. The incoming physician would join an established team that is currently operating at full capacity.
Bassam Abi-Rached, MD (profile)
Specialty: Medical Oncology, Hematology Oncology
Location: Cabrini Cancer Center North
Medical School: Lebanese University School of Medicine, Faculty of Medical Sciences
Residency: State University of New York Downstate Medical Center
Fellowship: New York-Presbyterian University Hospital of Columbia and Cornell
Baochong Chang, MD (profile)
Specialty: Hematology Oncology
Location: Cabrini Cancer Center South
Medical School: Xuzhou Medical College and Clark University
Residency: Michigan State University
Fellowship: University of Texas Health Science Center at Houston
Hafez Halawani, MD (profile)
Specialty: Medical Oncology, Hematology
Location: Cabrini Cancer Center South
Medical School: Jordan University of Science and Technology Faculty of Medicine
Residency: Wright Center for Graduate Medical Education; Scranton Temple Residency
Fellowship: Baystate Medical Center
The APP team takes first call and works up new ED and inpatient consults. A fourth APP is planned once the new physician is in-house.
| Location | Address | Phone |
|---|---|---|
| Cabrini Cancer Center South | 3330 Masonic Dr., Alexandria, LA 71301 | 318-448-6917 |
| Cabrini Cancer Center North | 2108 Texas Ave., Suite 3061, Alexandria, LA 71301 | 318-442-2232 |
The current team has built its referral base through the CHRISTUS hospital-employed primary care network and works closely with on-site radiation oncology, surgical specialties, hospice, and palliative care services. The cancer center’s CoC accreditation reflects an established multidisciplinary care model. The incoming physician would step into an existing patient base supported by full infusion capacity, on-site imaging at the hospital, and three-deep APP coverage.